General · 23 June 2026

Type 1 diabetes drug delays onset by three years

This is the first treatment of its kind, offering people up to three extra years before needing daily insulin for type 1 diabetes. NICE, the health guidance body, approved teplizumab for children aged eight and over and adults with early-stage disease. Around 1,100 people could be eligible in the first year for the 14-day course.

By BriefTea Editorial · 23 June 2026 at 7:24

Reported by BBC · How we write briefs

Get the app

More briefs

GeneralGoogle paying £260m to settle UK Play Store developer lawsuit PoliticsJames Cleverly steps down from the shadow cabinet to campaign for London mayor GeneralThe UK Navy just followed four Russian ships again GeneralSarah Ferguson is moving back to the UK following the Epstein scandal GeneralIcelanders vote on restarting EU membership talks after 13 years GeneralGoogle now auto-expands AI answers, pushing links down Browse all stories →